Plus Therapeutics(PSTV) - 2023 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34375 PLUS THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) DELAWARE 33-0827593 (State or other jurisdiction of incorporation or organization) 4200 MARATHON BLVD., SUITE 200, AUSTIN, TX 78756 (Address of principal executive offices) (Zip Code) For the quarterly period ended Se ...